You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 8 No. 1, January 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Krabbe's Disease

Globoid Cell Type of Leukodystrophy

ANTHONY N. D'AGOSTINO, M.D.; GEORGE P. SAYRE, M.D.; ALVIN B. HAYLES, M.D.

Arch Neurol. 1963;8(1):82-96.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The demyelinating diseases are characterized by a primary breakdown of myelin with more or less persistence of the axis cylinders and with secondary proliferation of astrocytes and microglial cells leading to sclerosis. The demyelination may be disseminated, as in multiple sclerosis, or diffuse. A disorder first described by Krabbe1 in 1916 and known since then as Krabbe's disease is an example of the diffuse type of cerebral sclerosis.

In the disseminated type of sclerosis numerous discrete, demyelinating foci of variable size are scattered throughout the brain and spinal cord. In the diffuse type, the lesions begin in one focus in the cerebral hemispheres and spread to involve adjacent white matter in a continuous fashion. Ultimately the demyelination extends from the paraventricular areas to the cortex, and usually it becomes bilateral and symmetrical.

The classifications of the diffuse demyelinating diseases have undergone considerable revision since the development of histochemical . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN.

Fellow in Pathology, Mayo Foundation (Dr. D'Agostino), Section of Pathologic Anatomy (Dr. Sayre), and Section of Pediatrics (Dr. Hayles), Mayo Clinic and Mayo Foundation.


Footnotes

Submitted for publication June 11, 1962.

This investigation was supported in part by Research Grant No. 2B5307 from the National Institutes of Health, Public Health Service.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.